Showing results (1341-1350 of 1,356) with videos related to
Sort By:
Pageof 136
Clinical and Experimental Dermatology|June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World StudyFrancesca Barei, Stefano Macchi, Paolo Calzari, et al.BJU International|June 20, 2020
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational studyBernardo Rocco, Maria Chiara Sighinolfi, Marco Sandri, et al.Clinical and Experimental Dermatology|April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN StudyMarina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2019
Italian Guidelines in diagnosis and treatment of alopecia areataAlfredo Rossi, Marta Muscianese, Bianca M Piraccini, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian studyB M Piraccini, F Pampaloni, S Cedirian, et al.Italian Journal of Dermatology and Venereology|May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patientsBianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.Science (New York, N.Y.)|December 15, 2010
Genome expansion and gene loss in powdery mildew fungi reveal tradeoffs in extreme parasitismPietro D Spanu, James C Abbott, Joelle Amselem, et al.Expert Opinion on Biological Therapy|November 20, 2020
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.American Journal of Clinical Dermatology|March 19, 2026
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World StudyMichela Starace, Luca Rapparini, Francesca Pampaloni, et al.Pageof 136